南方医科大学学报 ›› 2026, Vol. 46 ›› Issue (9): 2185-2195.doi: 10.12122/j.issn.1673-4254.2026.09.17
• • 上一篇
梁云腾1(
), 高倩2, 李悦怡1, 黄菁宇1, 刘凯鲁1, 洪艳丽1, 周惠芳1, 聂晓伟1(
)
收稿日期:2025-12-28
出版日期:2026-09-20
发布日期:2026-09-30
通讯作者:
聂晓伟
E-mail:15269546010@163.com;niexiao5715@163.com
作者简介:梁云腾,在读硕士研究生,E-mail: 15269546010@163.com
基金资助:
Yunteng LIANG1(
), Qian GAO2, Yueyi LI1, Jingyu HUANG1, Kailu LIU1, Yanli HONG1, Huifang ZHOU1, Xiaowei NIE1(
)
Received:2025-12-28
Online:2026-09-20
Published:2026-09-30
Contact:
Xiaowei NIE
E-mail:15269546010@163.com;niexiao5715@163.com
Supported by:摘要:
目的 探讨五子衍宗丸对卵巢储备功能减退小鼠的治疗作用及潜在机制。 方法 利用雷公藤多苷建立卵巢储备功能减退小鼠模型,将雌性C57BL/6J小鼠随机分为对照组、模型组、五子衍宗丸低剂量组(五子衍宗丸-L,1.82 g·kg-1·d-1)和五子衍宗丸高剂量组(五子衍宗丸-H,3.64 g·kg-1·d-1),8只/组,灌胃给药28 d。计算小鼠卵巢指数,通过ELISA检测激素水平,HE染色观察卵巢组织形态。利用RNA-seq筛选五子衍宗丸治疗卵巢储备功能减退的关键信号通路。结合网络药理学,使用多重数据库分析五子衍宗丸的潜在作用靶点与通路。通过免疫组化和Western blotting检测小鼠卵巢组织中TGF-β1/PI3K/Akt/mTOR通路关键蛋白表达,TUNEL染色及Western blotting评估颗粒细胞(GCs)凋亡水平。此外,收集人GCs样本进行Western blotting,验证该通路在卵巢储备功能减退患者中的表达。 结果 与模型组相比,五子衍宗丸使卵巢指数恢复(P<0.05),抗缪勒管激素及雌二醇水平升高,卵泡刺激素降低(P<0.05),并改善卵巢组织形态,使GCs功能恢复,闭锁卵泡减少。RNA-seq显示PI3K/Akt通路在五子衍宗丸治疗后显著富集。网络药理学显示,TGF-β、PI3K-Akt及凋亡通路是五子衍宗丸潜在作用的关键通路。免疫组化及Western blotting提示五子衍宗丸上调卵巢组织TGF-β1、PI3K、Akt和mTOR蛋白表达(P<0.05),TUNEL染色及Western blotting表明五子衍宗丸抑制GCs凋亡(P<0.05)。卵巢储备功能减退患者GCs中TGF-β1/PI3K/Akt/mTOR通路蛋白表达下调(P<0.05)。 结论 五子衍宗丸通过上调TGF-β1/PI3K/Akt/mTOR信号通路,抑制GCs过度凋亡,从而改善卵巢储备功能。
梁云腾, 高倩, 李悦怡, 黄菁宇, 刘凯鲁, 洪艳丽, 周惠芳, 聂晓伟. 五子衍宗丸通过调控TGF-β1/PI3K/Akt/mTOR通路抑制颗粒细胞凋亡改善卵巢储备功能减退[J]. 南方医科大学学报, 2026, 46(9): 2185-2195.
Yunteng LIANG, Qian GAO, Yueyi LI, Jingyu HUANG, Kailu LIU, Yanli HONG, Huifang ZHOU, Xiaowei NIE. Wuzi Yanzong Pill ameliorates diminished ovarian reserve in mice by inhibiting granulosa cell apoptosis via the TGF-β1/PI3K/Akt/mTOR pathway[J]. Journal of Southern Medical University, 2026, 46(9): 2185-2195.
图1 五子衍宗丸减轻TWP诱导的卵巢毒性
Fig.1 Wuzi Yanzong Pill (WZYZP) alleviates Tripterygium wilfordii polyglycoside-induced ovarian toxicity. A: Animal experimental protocol. B: Comparison of ovarian index among the groups. C-E: ELISA detection of AMH, FSH, and E2 levels in each group. F: HE staining of the ovarian tissues in each group (Scale bar=100 μm or 50 μm). Data are presented as Mean±SD (n=8). DOR: Diminished ovarian reserve; AMH: Anti-Müllerian hormone; E2: Estradiol; FSH:Follicle stimulating hormone. *P<0.05, ***P<0.001 vs CON group, #P<0.05, ##P<0.01, ###P<0.001 vs DOR group.
图2 RNA-seq检测WZYZP处理前后小鼠卵巢颗粒细胞的转录水平
Fig.2 RNA-seq of transcriptional levels in mice granulosa cells (GCs) before and after WZYZP treatment. A: Volcano plot of differentially expressed genes in mice GCs before and after WZYZP treatment (n=3). B: Heatmap of differentially expressed genes in mice GCs before and after WZYZP treatment (n=3). C: GO analysis of differentially expressed genes (n=3). D: Dotplot of KEGG pathway enrichment analysis (n=3).
图3 网络药理学探讨五子衍宗丸(WZYZP)治疗卵巢储备功能减退(DOR)的作用机制
Fig.3 Network pharmacology analysis of the mechanisms of WZYZP for treating diminished ovarian reserve (DOR). A: Venn diagram of shared targets between WZYZP and DOR. B: Medicine-component-target-disease map. C: PPI network diagram. D: GO analysis of the shared targets, categorized into Biological Processes (BP), Cellular Components (CC), and Molecular Functions (MF). E: Dotplot of KEGG pathway enrichment analysis.
图4 五子衍宗丸上调DOR小鼠中TGF-β1、PI3K及Akt的表达
Fig.4 WZYZP upregulates ovarian expressions of TGF-β1, PI3K, and Akt in DOR mice. A: Immunohistochemistry for TGF-β1, PI3K and Akt in mouse ovaries (Scale bar=50 μm or 20 μm). B-D: Expression levels of TGF-β1, PI3K and Akt in mouse ovaries (Mean±SD, n=5). *P<0.05, **P<0.01, ***P<0.001 vs CON group; #P<0.05, ##P<0.01, ###P<0.001 vs DOR group.
图7 DOR患者颗粒细胞中TGF-β1/PI3K/Akt/mTOR信号通路下调及凋亡相关蛋白上调
Fig.7 Down-regulation of the TGF-β1/PI3K/Akt/mTOR signaling pathway and up-regulation of apoptosis-related proteins in GCs of DOR patients. A: Protein bands of TGF-β1, PI3K, Akt, and mTOR detected by Western blotting. B: Quantitative analysis of TGF-β1, PI3K, Akt, and mTOR protein expression levels. C: Protein bands of caspase-3, BAX, and Bcl-2 detected by Western blotting. D: Quantitative analysis of caspase3, BAX, and Bcl-2 protein expression levels. Data are presented as Mean±SD (n=3). **P<0.01, ***P<0.001 vs CON group.
| [1] | Li HY, Cai SY, Mu HB, et al. HIGD1A alleviates oxidative stress related ovarian hypofunction by enhancing granulosa cell functions via NF‑κB/SOD2 signaling pathway[J]. Adv Sci, 2025, 12(34): e03828. doi:10.1002/advs.202503828 |
| [2] | Hu NY, Xin N, Wang Y, et al. CTB alleviated premature ovarian insufficiency induced by cigarette smoke exposure in mice through activating CREB1 by P300-mediated histone acetylation modifications[J]. Ecotoxicol Environ Saf, 2025, 302: 118625. doi:10.1016/j.ecoenv.2025.118625 |
| [3] | Zhang QL, Lei YL, Deng Y, et al. Treatment progress in diminished ovarian reserve: western and Chinese medicine[J]. Chin J Integr Med, 2023, 29(4): 361-7. doi:10.1007/s11655-021-3353-2 |
| [4] | Han PN, Xu HS, Yuan YY, et al. The role of growth hormone in assisted reproductive technology for patients with diminished ovarian reserve: from signaling pathways to clinical applications[J]. Front Endocrinol, 2025, 16: 1551126. doi:10.3389/fendo.2025.1551126 |
| [5] | Pastore LM, Christianson MS, Stelling J, et al. Reproductive ovarian testing and the alphabet soup of diagnoses: DOR, POI, POF, POR, and FOR[J]. J Assist Reprod Genet, 2018, 35(1): 17-23. doi:10.1007/s10815-017-1058-4 |
| [6] | Gao F, Yu Y, Wang FW, et al. The altered hypothalamic network functional connectivity in diminished ovarian reserve and regulation effect of acupuncture: a randomized controlled neuroimaging study protocol[J]. Front Endocrinol, 2025, 16: 1598943. doi:10.3389/fendo.2025.1598943 |
| [7] | Armeni E, Paschou SA, Goulis DG, et al. Hormone therapy regimens for managing the menopause and premature ovarian insufficiency[J]. Best Pract Res Clin Endocrinol Metab, 2021, 35(6): 101561. doi:10.1016/j.beem.2021.101561 |
| [8] | Cao WL, Liu SL, Zhang LF, et al. Therapeutic strategies in traditional Chinese medicine for premature ovarian failure: Modulation of oxidative stress and autophagy-apoptosis via the AMPK/mTOR pathway[J]. Biosci Trends, 2025, 19(5): 545-56. doi:10.5582/bst.2025.01193 |
| [9] | Cui FL, Zhang YS, Fan Y. Adjuvant treatment with Wu-Zi-Yan-Zong formula for abnormal sperm parameters associated with male infertility: a meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2025, 16: 1580705. doi:10.3389/fphar.2025.1580705 |
| [10] | Chen ZM, Mingyue AO, Liao YJ, et al. Wuzi Yanzong prescription from Traditional Chinese Medicine for male infertility: a narrative review[J]. J Tradit Chin Med, 2023, 43(2): 416-28. |
| [11] | 朱芳芳, 王焱皙, 郜 洁, 等. 基于自噬研究麒麟丸对环磷酰胺诱导的卵巢储备功能减退模型小鼠卵巢储备功能的影响[J]. 中华中医药杂志, 2021, 36(4): 1989-94. |
| [12] | 纪利娜, 张秀艳, 梁紫影, 等. 加味五子衍宗丸周期分期治疗对卵巢低反应肾虚证患者助孕结局的影响[J]. 中国实验方剂学杂志, 2021, 27(14): 106-10. doi:10.13422/j.cnki.syfjx.20210234 |
| [13] | Dumesic DA, Meldrum DR, Katz-Jaffe MG, et al. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health[J]. Fertil Steril, 2015, 103(2): 303-16. doi:10.1016/j.fertnstert.2014.11.015 |
| [14] | Shen T, Yu Q, Zhang J, et al. Jiawei Qingxin Zishen Decoction mitigates granulosa cell apoptosis and enhances ovarian reserve through Netrin/UNC5B signaling pathway[J]. J Ethnopharmacol, 2026, 355: 120686. doi:10.1016/j.jep.2025.120686 |
| [15] | Chen W, Dong L, Liang QH, et al. NEAT1 inhibits granulosa cell apoptosis and promotes cell growth and migration through the miR-130a-3p/BMP6 axis[J]. Reprod BioMedicine Online, 2025, 51(6): 104870. doi:10.1016/j.rbmo.2025.104870 |
| [16] | Fan YT, Chang YJ, Wei LN, et al. Apoptosis of mural granulosa cells is increased in women with diminished ovarian reserve[J]. J Assist Reprod Genet, 2019, 36(6): 1225-35. doi:10.1007/s10815-019-01446-5 |
| [17] | Hu LL, Su T, Luo RC, et al. Hippo pathway functions as a downstream effector of AKT signaling to regulate the activation of primordial follicles in mice[J]. J Cell Physiol, 2019, 234(2): 1578-87. doi:10.1002/jcp.27024 |
| [18] | Bindels J, Squatrito M, Bernet L, et al. The mTOR inhibitor rapamycin counteracts follicle activation induced by ovarian cryopreservation in murine transplantation models[J]. Medicina, 2023, 59(8): 1474. doi:10.3390/medicina59081474 |
| [19] | Chen JZ, Wang NN, Peng ZL, et al. Zishen Yutai pill ameliorates ovarian reserve by mediating PI3K-Akt pathway and apoptosis level in ovary[J]. J Ovarian Res, 2025, 18(1): 61. doi:10.1186/s13048-025-01643-0 |
| [20] | Zatalian N, Dalman A, Afsharian P, et al. Metformin protects prepubertal mice ovarian reserve against cyclophosphamide via regulation of the PI3K/Akt/mTOR signaling pathway and Yap-1[J]. J Ovarian Res, 2024, 17(1): 251. doi:10.1186/s13048-024-01572-4 |
| [21] | Wang C, Feng Y, Chen Y, et al. Proximity extension assay revealed novel inflammatory biomarkers for follicular development and ovarian function: a prospective controlled study combining serum and follicular fluid[J]. Front Endocrinol, 2025, 16: 1525392. doi:10.3389/fendo.2025.1525392 |
| [22] | 黄菁宇. 补肾促排卵汤通过表观遗传修饰改善DOR小鼠氧化应激的机制研究[D]. 南京: 南京中医药大学, 2022. |
| [23] | Vidal-Sabanés M, Bonifaci N, Navaridas R, et al. Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503[J]. Cell Death Dis, 2025, 16: 705. doi:10.1038/s41419-025-08022-z |
| [24] | Liu Y, Jiang LJ, Liu HF, et al. Distinct roles of HMOX1 on tumor epithelium and macrophage for regulation of immune microenvironment in ovarian cancer[J]. Int J Surg, 2025, 111(10): 6725-42. doi:10.1097/js9.0000000000002829 |
| [25] | Hu WJ, Xie X, Xu JB. Epimedium-derived exosome-loaded GelMA hydrogel enhances MC3T3-E1 osteogenesis via PI3K/Akt pathway[J]. Cells, 2025, 14(15): 1214. doi:10.3390/cells14151214 |
| [26] | Zhou JJ, Qiao E, He ZY, et al. Fibulin 5 mediates pulmonary artery smooth muscle cell dysfunction and vascular remodelling in congenital heart disease associated pulmonary arterial hypertension via TGF-β1/PI3K/AKT signalling[J]. Respir Res, 2025, 26(1): 276. doi:10.1186/s12931-025-03361-z |
| [27] | 何瑞芬, 杨永秀, 梁晓磊. 卵巢储备功能减退动物模型研究进展[J]. 中国实验动物学报, 2024, 32(2): 254-9. |
| [28] | 林华丹, 王 旭, 陈春宏, 等. 三种卵巢储备功能减退小鼠模型的效果比较[J]. 中国比较医学杂志, 2025, 37(5): 51-9. |
| [29] | Jiang S, Li HQ, Zhang L, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics[J]. Nucleic Acids Res, 2025, 53(D1): D1670-6. doi:10.1093/nar/gkae973 |
| [30] | Monteleone P, Mascagni G, Giannini A, et al. Symptoms of menopause: global prevalence, physiology and implications[J]. Nat Rev Endocrinol, 2018, 14(4): 199-215. doi:10.1038/nrendo.2017.180 |
| [31] | Dong L, Wu HC, Qi FH, et al. LncRNA NEAT1 participates in diminished ovarian reserve by affecting granulosa cell apoptosis and estradiol synthesis via the miR-204-5p/ESR1 axis[J]. J Ovarian Res, 2025, 18(1): 102. doi:10.1186/s13048-025-01683-6 |
| [32] | Zhang XY, Zhang N, Dong ZB, et al. The role of Chinese herbal medicine in diminished ovarian reserve management[J]. J Ovarian Res, 2025, 18(1): 90. doi:10.1186/s13048-025-01669-4 |
| [33] | 陈 瑶, 田赛男, 王彬安, 等. 归肾丸治疗卵巢功能减退性疾病的作用机制研究进展[J]. 中国实验方剂学杂志, 2026, 32(2): 317-24. |
| [34] | 李 瑄, 林 蓉, 苏嘉文, 等. 滋肾安神汤联合生长激素对卵巢储备功能减退患者体外受精-胚胎移植临床结局的影响[J]. 实用医学杂志, 2025, 41(20): 3283-7. doi:10.3969/j.issn.1006-5725.2025.20.019 |
| [35] | 辛喜艳, 鞠瀚儒, 李 东. 补肾调血法改善卵巢储备功能减退患者IVF-ET妊娠结局的中医机理探讨[J]. 中国中医基础医学杂志, 2025, 31(10): 1730-4. |
| [36] | 高语浓. 加减五子衍宗丸干预肾虚肝郁证DOR不孕症IVF-ET临床疗效观察[D]. 沈阳: 辽宁中医药大学, 2025. |
| [37] | 卵巢储备功能减退临床诊治专家共识专家组;中华预防医学会生育力保护分会生殖内分泌生育保护学组.卵巢储备功能减退临床诊治专家共识[J]. 生殖医学杂志, 2022, 31(4): 425-34. |
| [38] | Carson SA, Kallen AN. Diagnosis and management of infertility: a review[J]. JAMA, 2021, 326(1): 65-76. doi:10.1001/jama.2021.4788 |
| [39] | Bai Q, Ban YW, Zhao LF, et al. Mitochondrial protein COX5B orchestrates antiviral autophagy and apoptosis to restrict SRBSDV propagation in Sogatella furcifera [J]. Autophagy, 2026: 22(3): 567-85. doi:10.1080/15548627.2025.2601863 |
| [40] | Andrade GM, da Silveira JC, Perrini C, et al. The role of the PI3K-Akt signaling pathway in the developmental competence of bovine oocytes[J]. PLoS One, 2017, 12(9): e0185045. doi:10.1371/journal.pone.0185045 |
| [41] | He YX, Gan ML, Ma JF, et al. TGF‑β signaling in the ovary: Emerging roles in development and disease[J]. Int J Biol Macromol, 2025, 306(Pt 4): 141455. doi:10.1016/j.ijbiomac.2025.141455 |
| [42] | Luo KX. Signaling cross talk between TGF‑β/smad and other signaling pathways[J]. Cold Spring Harb Perspect Biol, 2017, 9(1): a022137. doi:10.1101/cshperspect.a022137 |
| [43] | Tang QY, Markby GR, MacNair AJ, et al. TGF‑β‑induced PI3K/AKT/mTOR pathway controls myofibroblast differentiation and secretory phenotype of valvular interstitial cells through the modulation of cellular senescence in a naturally occurring in vitro canine model of myxomatous mitral valve disease[J]. Cell Prolif, 2023, 56(6): e13435. doi:10.1111/cpr.13435 |
| [44] | Li MN, Wang LB, Luo YZ, et al. RNA-seq analysis of the biological process and regulatory signal of TGF‑β1-mediated changes in ovarian granulosa cells in small-tail Han sheep[J]. Theriogenology, 2025, 234: 9-18. doi:10.1016/j.theriogenology.2024.12.001 |
| [45] | Jiang LL, Yang SJ, Zhang CL. Sigma-1 receptor-mediated high mobility group A1 silencing alleviates endoplasmic reticulum stress-induced ovarian granulosa cell apoptosis: an in vitro cell experimental study[J]. BJOG, 2025, 132(): 120-31. doi:10.1111/1471-0528.18081 |
| [46] | Yan JM, Zhang XY, Zhu KX, et al. Sleep deprivation causes gut dysbiosis impacting on systemic metabolomics leading to premature ovarian insufficiency in adolescent mice[J]. Theranostics, 2024, 14(9): 3760-76. doi:10.7150/thno.95197 |
| [47] | Xue HW, Zhang SY, Lu J, et al. Pfaffia glomerata ameliorates BPA-induced reproductive impairments in mice by suppressing apoptosis via PI3K/AKT signaling activation[J]. Pharmaceuticals, 2025, 18(11): 1614. doi:10.3390/ph18111614 |
| [48] | Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis[J]. J Cell Biol, 2022, 221(6): e202201159. doi:10.1083/jcb.202201159 |
| [1] | 李春宁, 杨琪琪, 张振丰, 鲍亮, 姜天鑫, 张玉, 李飞. 电针通过调控TLR4/MyD88/NF-κB信号通路减轻膝关节骨关节炎大鼠膝关节软骨凋亡[J]. 南方医科大学学报, 2026, 46(8): 1886-1895. |
| [2] | 张雨, 孙康, 刘举达, 王舒晗, 裴静. 消核冲剂激活ASK1/MKK4/JNK通路促进乳腺上皮细胞凋亡改善大鼠乳腺增生分子机制[J]. 南方医科大学学报, 2026, 46(8): 1936-1946. |
| [3] | 乔通, 张龙涛, 章雨, 黄菊, 李晴晴, 耿志军, 胡建国, 李静. 异香草酸激活PPARγ通路改善线粒体功能缓解葡聚糖硫酸钠诱导的小鼠溃疡性结肠炎[J]. 南方医科大学学报, 2026, 46(7): 1487-1497. |
| [4] | 张龙涛, 章雨, 乔通, 张可妮, 尹林, 黄菊, 李静, 耿志军, 胡建国. 丁香酸甲酯通过抑制MAPK通路调控肠上皮细胞凋亡减轻葡聚糖硫酸钠诱导的小鼠结肠炎[J]. 南方医科大学学报, 2026, 46(7): 1685-1695. |
| [5] | 李瑾, 贺一杰, 毕芳芳, 陈浚鑫, 范桢颜, 张宇, 陈恩宇, 肖鸿文, 吴云, 田华, 周宇宏. 靶向抑制miR-503可通过上调Apelin表达减轻小鼠心肌梗死损伤[J]. 南方医科大学学报, 2026, 46(6): 1235-1243. |
| [6] | 于静, 储继军, 梁程程. 慢性铁过载通过铁代谢紊乱引发氧化应激与内分泌失调诱导小鼠卵巢储备功能减退[J]. 南方医科大学学报, 2026, 46(6): 1313-1322. |
| [7] | 魏佳, 蒋伟, 夏林莺, 吕侣, 杨强. GDF11通过抑制硫氧还蛋白1硝基化失活减轻心肌缺血/再灌注损伤[J]. 南方医科大学学报, 2026, 46(5): 1075-1083. |
| [8] | 林雨星, 石思楠, 汪婧, 林思悦, 张杰, 林珊珊, 陈伊舒榕, 张铃, 蔡巧燕. 清达颗粒下调P53信号通路抑制高血压小鼠脑微血管内皮细胞凋亡[J]. 南方医科大学学报, 2026, 46(5): 1102-1110. |
| [9] | 马丹, 曹书源, 姜毅, 彭煜策, 何岸, 罗明昊, 罗素新. 褪黑素通过抑制STING信号通路减轻糖尿病小鼠心肌细胞坏死性凋亡[J]. 南方医科大学学报, 2026, 46(5): 1157-1166. |
| [10] | 宋淇乐, 苗益恺, 冯小桐, 王一凡, 刘伟, 魏琪, 于新汝, 陈文文, 付晓艳. 硒代胱氨酸通过诱导活性氧产生启动氧化应激损伤抑制结肠癌细胞生长[J]. 南方医科大学学报, 2026, 46(3): 532-540. |
| [11] | 温贺新, 林洁, 左芦根, 刘牧林. 珠子草素通过拮抗肠上皮细胞凋亡与调控肠道Th1/Th2免疫平衡改善克罗恩病样小鼠结肠炎[J]. 南方医科大学学报, 2026, 46(3): 655-665. |
| [12] | 张语洋, 申颖, 佟欣雨, 段宇魁, 罗云娜, 郭文奇. 水飞蓟宾通过诱导细胞自噬及凋亡双重机制抑制兔青光眼术后纤维化[J]. 南方医科大学学报, 2026, 46(3): 666-674. |
| [13] | 乔通, 尹林, 张可妮, 牛民主, 黄菊, 耿志军, 李静, 胡建国. 茯苓新酸A通过调节AMPK/mTOR介导的自噬来减轻葡聚糖硫酸钠诱导的小鼠结肠炎[J]. 南方医科大学学报, 2026, 46(1): 131-140. |
| [14] | 张淑芬, 黄添容, 杨灿洪, 陈家镒, 吕田明, 张嘉发. 莱菔硫烷通过抑制Aβ42寡聚体激活的U87细胞中MAPK/NF-κB信号通路降低反应性星形胶质细胞介导的SH-SY5Y凋亡[J]. 南方医科大学学报, 2026, 46(1): 191-199. |
| [15] | 赵锦燕, 彭娇, 林明和, 朱晓勤, 黄彬, 林久茂. 清解扶正颗粒通过抑制线粒体依赖的凋亡、激活AMPK-PGC-1α通路缓解5-氟尿嘧啶引起的骨骼肌损伤[J]. 南方医科大学学报, 2026, 46(1): 94-103. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||